Healthy Japanese subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Men or women 3. Subjects aged 45 or more 4. Healthy subjects 5. Subjects with 20 or more natural teeth 6. Subjects who have mild periodontal disease
Exclusion criteria
Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" 5. Subjects who are taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products (particularly fish or gelatin) 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician 10. Subjects who use artificial tooth, post crowns, dentures, implants or bridges 11. Subjects who use floss, interdental brushes, and mouthwash at brushing their teeth 12. Subjects who have undergone dental maintenance such as plaque and tartar removal at a dental clinic within the last 3 months before obtaining consent, or who are planning to undergo maintenance during this trial 13. Subjects who regularly use gargle medicine 14. Subjects with past or present history related to salivary gland disease (such as sialadenitis, sialolithiasis, Sjogren syndrome, or tumor of salivary gland), or who have undergone salivary gland removal 15. Subjects undergoing treatment for dental disease 16. Subjects who are smokers, or started smoking cessation within one year before the agreement to participate in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment items for periodontal disease | — |
Countries
Japan
Contacts
ORTHOMEDICO Inc. R&D Department